undamentalytics Newsletter

P3 Health Partners Inc. income statement

In fiscal 2025, P3 Health Partners Inc. reported revenue of $1.46bn, down 2.8% on the year before, operating income of −$270m (a -18.5% margin) and net income of −$148m, or −$45.26 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

P3 Health Partners Inc.: income statement, annual
Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1454915791,0491,2661,5001,4591,503
Selling and marketing1225311—
General and administrative3653100157122113106116
Operating income−40−29−129−1,561−168−321−270−149
Net interest income−3−3−10−11−16−22−55−61
Provision for credit losses—————03—
Income before tax−42−31−146−1,560−184−306−321−227
Income tax0002342−11
Net income−42−31−146−270−58−136−148−98
Diluted EPS———−$650.00−$63.00−$54.06−$45.26−$21.48
Diluted shares (average)————3m3m3m5m
EBITDA−39−28−127−1,474−81−235−186−64

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ADUS vs PIIIHQY vs PIIIPGNY vs PIII

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from P3 Health Partners Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to P3 Health Partners Inc.